Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy
NCT ID: NCT06301152
Last Updated: 2024-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2022-09-01
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Material and methods: Forty five participants (age range, 18 to 65 years) with unilateral elbow pain were randomized into two groups. HILT group (n = 22) and the ESWT group (n = 23). The HILT and ESWT were administered three times a week for three weeks, and each treatment was combined with exercises. All patients in both groups were evaluated with ultrasonography for common extensor tendon(CET) thickness. A visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QDASH), and hand grip strength test were used to evaluate the patients before, one, and six weeks after treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiotherapy Applications in Lateral Epicondylitis
NCT07028840
ESWT in Lateral Epicondylitis: Clinical,Ultrasonographic Evaluation
NCT06342518
Effectiveness of Radial Extracorporeal Shock Wave Therapy and Supervised Exercises in Lateral Epicondylitis
NCT03834090
Combined Isotonic Exercise in the Treatment of Lateral Epicondylitis
NCT07170839
Efficacy of Extracorporeal Shock Wave Therapy, Ultrasound and Phonophoresis Treatments in Lateral Epicondylitis
NCT05334953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high intensive laser
high-intensity laser was applied 3 times in a week, for three weeks, total of 9 sessions
high intensive laser
high-intensity laser ,three times in a week, for three weeks, 9 session
extracorporeal shock wave therapy
extracorporeal shock wave therapy was applied once a week, for three weeks total of 3 sessions
extracorporeal shock wave therapy
extracorporeal shock wave therapy, once a week, for three weeks ,3 times,
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high intensive laser
high-intensity laser ,three times in a week, for three weeks, 9 session
extracorporeal shock wave therapy
extracorporeal shock wave therapy, once a week, for three weeks ,3 times,
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>18
Exclusion Criteria
* Received physical therapy, or had a steroid injection to the elbow in the three months
* Cervical radiculopathy,
* Elbow deformities,
* Fibromyalgia syndrome,
* Carpal tunnel syndrome,
* Neurological impairments in the upper extremity,
* Chronic inflammatory conditions,
* Hemophilia,
* Pregnant,
* History of malignancy
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emine Esra Bilir
Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E2-22-1905
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.